WallStSmart

Alcon AG (ALC)vsIntuitive Surgical Inc (ISRG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Intuitive Surgical Inc generates 4% more annual revenue ($11.03B vs $10.63B). ISRG leads profitability with a 28.4% profit margin vs 7.7%. ALC appears more attractively valued with a PEG of 1.52. ISRG earns a higher WallStSmart Score of 66/100 (B-).

ALC

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 4.5Value: 3.3Quality: 6.8
Piotroski: 3/9

ISRG

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 9.0Value: 6.0Quality: 7.8
Piotroski: 4/9Altman Z: 5.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ALCSignificantly Overvalued (-25.0%)

Margin of Safety

-25.0%

Fair Value

$63.50

Current Price

$70.99

$7.49 premium

UndervaluedFair: $63.50Overvalued
ISRGUndervalued (+81.6%)

Margin of Safety

+81.6%

Fair Value

$1922.89

Current Price

$368.26

$1554.63 discount

UndervaluedFair: $1922.89Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ALC2 strengths · Avg: 8.5/10
Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

ISRG6 strengths · Avg: 9.0/10
Operating MarginProfitability
33.8%10/10

Strong operational efficiency at 33.8%

Altman Z-ScoreHealth
5.9510/10

Safe zone — low bankruptcy risk

Market CapQuality
$122.06B9/10

Large-cap with strong market position

Profit MarginProfitability
28.4%9/10

Keeps 28 of every $100 in revenue as profit

Revenue GrowthGrowth
18.5%8/10

18.5% revenue growth

EPS GrowthGrowth
26.5%8/10

Earnings expanding 26.5% YoY

Areas to Watch

ALC4 concerns · Avg: 3.3/10
PEG RatioValuation
1.524/10

Expensive relative to growth rate

Return on EquityProfitability
3.7%3/10

ROE of 3.7% — below average capital efficiency

Profit MarginProfitability
7.7%3/10

7.7% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ISRG2 concerns · Avg: 3.0/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
40.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : ALC

The strongest argument for ALC centers on Debt/Equity, Price/Book.

Bull Case : ISRG

The strongest argument for ISRG centers on Operating Margin, Altman Z-Score, Market Cap. Profitability is solid with margins at 28.4% and operating margin at 33.8%. Revenue growth of 18.5% demonstrates continued momentum.

Bear Case : ALC

The primary concerns for ALC are PEG Ratio, Return on Equity, Profit Margin. A P/E of 41.4x leaves little room for execution misses.

Bear Case : ISRG

The primary concerns for ISRG are PEG Ratio, P/E Ratio. A P/E of 40.2x leaves little room for execution misses.

Key Dynamics to Monitor

ALC profiles as a value stock while ISRG is a growth play — different risk/reward profiles.

ISRG carries more volatility with a beta of 1.46 — expect wider price swings.

ISRG is growing revenue faster at 18.5% — sustainability is the question.

ISRG generates stronger free cash flow (948M), providing more financial flexibility.

Bottom Line

ISRG scores higher overall (66/100 vs 49/100), backed by strong 28.4% margins and 18.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Alcon AG

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.

Visit Website →

Intuitive Surgical Inc

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA

Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.

Want to dig deeper into these stocks?